Implementing a pre-operative infection prevention "bundle" was associated with a significant reduction in serious S aureus surgical site infections.
A study published in JAMA evaluated whether the implementation of an evidence-based bundle would reduce the risk of S aureus infection at the surgical site in patients undergoing cardiac operations or hip or knee arthroplasties. The study, conducted in 20 hospitals across 9 states, asked patients identified with methicillin-resistant S aureus (MRSA) or methicillin-susceptible S aureus (MSSA), to follow a prophylactic regimen before surgery. Overall, the pre-operative intervention reduced the rate of surgical siteS aureus infections for hip or knee arthroplasties and for cardiac operations.
Read the paper at JAMA Network: http://bit.ly/1SW3zTi
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More